for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Microbix Biosystems Inc

MBX.TO

Latest Trade

0.59CAD

Change

0.00(0.00%)

Volume

148,702

Today's Range

0.59

 - 

0.60

52 Week Range

0.22

 - 

0.72

As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Microbix Reports Record Results For Q3 Fiscal 2021

Aug 12 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX REPORTS RECORD RESULTS FOR Q3 FISCAL 2021.Q3 REVENUE ROSE 88 PERCENT TO C$5.452 MILLION.EXPECTS TO GENERATE MEANINGFUL NET EARNINGS IN Q4 AND FOR FULL-YEAR FISCAL 2021.QTRLY NET INCOME OF $1.5 MILLION.

Microbix Posts Q2 Revenue Of C$4.354 Million

May 13 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX REPORTS RECORD RESULTS FOR Q2 FISCAL 2021.Q2 REVENUE ROSE 51 PERCENT TO C$4.354 MILLION.

Microbix Receives $4.25 Million Order For Viral Transport Medium

April 23 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX RECEIVES $4.25 MILLION ORDER FOR VIRAL TRANSPORT MEDIUM.

Microbix Reports Results For Fiscal 2020

Dec 18 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX REPORTS RESULTS FOR FISCAL 2020.Q4 REVENUE FELL 25 PERCENT TO C$2.706 MILLION.QTRLY NET COMPREHENSIVE LOSS PER SHARE $0.047.

Microbix Announces Board Changes

Sept 15 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX ANNOUNCES BOARD CHANGES.MICROBIX BIOSYSTEMS INC SAYS ITS FOUNDER AND EXECUTIVE CHAIRMAN WILLIAM J. (BILL) GASTLE HAS ELECTED TO RETIRE EFFECTIVE OCT 15, 2020.MICROBIX BIOSYSTEMS INC - MARTIN MARINO HAS BEEN NOMINATED TO BECOME INDEPENDENT CHAIRMAN OF ITS BOARD OF DIRECTORS.

Microbix Reports Qtrly Net Comprehensive Loss Per Share Of $0.004

Aug 14 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX REPORTS RESULTS FOR Q3 FISCAL 2020.Q3 REVENUE FELL 7 PERCENT TO C$2.898 MILLION.QTRLY NET COMPREHENSIVE LOSS PER SHARE OF $0.004.

Microbix Covid-19 QAPS Attain EU 'CE Mark' Registration

June 5 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX COVID-19 QAPS ATTAIN EU “CE MARK” REGISTRATION.MICROBIX BIOSYSTEMS - ATTAINED CE MARKING IN COMPLIANCE WITH EUROPEAN IN-VITRO DIAGNOSTIC DEVICES DIRECTIVE.MICROBIX BIOSYSTEMS - ALSO OBTAINED NATIONAL REGISTRATION WITH ITALIAN MINISTRY OF HEALTH FOR COVID-19 QAPS.

Microbix Biosystems Q2 Revenue Falls 32% To C$2.874 Million

May 14 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX REPORTS RESULTS FOR Q2 FISCAL 2020.Q2 REVENUE FELL 32 PERCENT TO C$2.874 MILLION.QTRLY NET COMPREHENSIVE LOSS PER SHARE $0.002.DURING Q2 MICROBIX RAISED $2,150,159 (NET OF ISSUE COSTS) IN A PRIVATE PLACEMENT.MICROBIX BIOSYSTEMS - FOR BALANCE OF 2020, WILL WORK TO CONTINUE IMPROVING PERCENTAGE GROSS MARGINS FROM CRITICAL INGREDIENTS (ANTIGENS) BUSINESS.

Microbix Reports Q1 Revenue Of C$2.046 Million

Feb 13 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX REPORTS RESULTS FOR Q1 FISCAL 2020.Q1 REVENUE FELL 17 PERCENT TO C$2.046 MILLION.QTRLY NET COMPREHENSIVE LOSS PER SHARE $0.006.

Microbix Says Q4 Revenue Rose 6% To C$3.587 Million

Dec 20 (Reuters) - Microbix Biosystems Inc <MBX.TO>::MICROBIX REPORTS RESULTS FOR FISCAL 2019.Q4 REVENUE ROSE 6 PERCENT TO C$3.587 MILLION.QTRLY LOSS PER SHARE $0.001.MICROBIX BIOSYSTEMS - FOR FISCAL 2020, CO WILL WORK TO CONTINUE IMPROVING PERCENTAGE GROSS MARGINS FROM ITS CRITICAL INGREDIENTS BUSINESS.MICROBIX BIOSYSTEMS - WORK CONTINUES WITH REGARDS TO SECURING PARTNERSHIP AGREEMENT TO ADVANCE MICROBIX'S KINLYTIC UROKINASE PROJECT.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up